BIOMAT Database Logo BIOMAT Database Logo

Inhibition of murine reaginic antibody responses by nasal immunotherapy with modified allergen. 1980

M J Schumacher, and G F Mitchell

Optimal conditions were established for induction of reaginic antibodies to Lolium perenne pollen allergens in mice by intranasal dosing of allergens with Bordetella pertussis vaccine. This antibody response could be inhibited by pretreatment of the mice by nasal administration of 100 microgram of glutaraldehyde-modified L. perenne allergens 9 times in 3 weeks before priming, whereas native allergens, in doses of 5 microgram, did not inhibit an IgE response to subsequent priming. It was not possible to suppress an ongoing reaginic antibody response by intranasal treatment with either native allergens, or glutaraldehyde-modified allergens. Relevance to immunoprophylaxis of allergic disease is discussed.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008297 Male Males
D008805 Mice, Inbred A An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mouse, Inbred A,Inbred A Mice,Inbred A Mouse
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D010567 Pertussis Vaccine A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) Vaccine, Pertussis
D011058 Pollen The fertilizing element of plants that contains the male GAMETOPHYTES. Male Gametes, Plant,Male Gametophytes,Microspores, Plant,Plant Microspores,Pollen Grains,Gamete, Plant Male,Gametes, Plant Male,Gametophyte, Male,Gametophytes, Male,Grain, Pollen,Grains, Pollen,Male Gamete, Plant,Male Gametophyte,Microspore, Plant,Plant Male Gamete,Plant Male Gametes,Plant Microspore,Pollen Grain
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D011935 Reagins Antibodies, especially IGE, that bind to tissue of the same species so that ANTIGENS induce HISTAMINE RELEASE and other vasoactive agents. HYPERSENSITIVITY is the clinical manifestation. Homocytotropic Antibodies,Reagin

Related Publications

M J Schumacher, and G F Mitchell
Cell-free detection of allergen-IgE cross-linking with immobilized phase CD23: inhibition by blocking antibody responses after immunotherapy.
October 2013, The Journal of allergy and clinical immunology,
M J Schumacher, and G F Mitchell
Birch pollen allergen-specific immunotherapy with glutaraldehyde-modified allergoid induces IL-10 secretion and protective antibody responses.
August 2019, Allergy,
M J Schumacher, and G F Mitchell
Effect of allergen immunotherapy on nasal responses in guinea-pigs with allergic rhinitis.
September 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
M J Schumacher, and G F Mitchell
Reaginic antibody receptors on murine mastocytoma cells.
October 1972, Journal of immunology (Baltimore, Md. : 1950),
M J Schumacher, and G F Mitchell
Modified forms of allergen immunotherapy.
August 1985, The Journal of allergy and clinical immunology,
M J Schumacher, and G F Mitchell
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.
January 2023, The Journal of allergy and clinical immunology,
M J Schumacher, and G F Mitchell
Safety of allergen-specific sublingual immunotherapy and nasal immunotherapy.
January 2003, Chemical immunology and allergy,
M J Schumacher, and G F Mitchell
Nasal challenges in allergen immunotherapy trials.
December 2018, Current opinion in allergy and clinical immunology,
M J Schumacher, and G F Mitchell
Nasal allergen challenge and immunotherapy control.
May 1998, Allergie et immunologie,
M J Schumacher, and G F Mitchell
Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity.
August 2005, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!